TABLE 1.

Clinical information for leprosy patients in this study^a

National origin	Age (yr)	Sex	WHO classification	Clinical specimen	Type of case	yr sample was obtained	Sample name
Brazil	30–39	F	Unknown	Skin biopsy	New case	2014	ML015
Bangladesh	50–59	M	PB	Skin biopsy	New case	2015	ML007
East Timor	30–39	M	Unknown	Skin biopsy	New case	2014	ML026
Indonesia	20–29	M	MB	Skin biopsy	New case	2014	ML025
Japan	80–89	F	MB	Skin biopsy	New case	2016	ML003
	70–79	F	MB	Skin-slit smear	Relapse	2014	ML009
	60–69	M	Unknown	Skin-slit smear	Relapse	2013	ML010
	80–89	F	Unknown	Skin biopsy	Relapse	2014	ML024
	70–79	M	MB	Skin biopsy	New case	2015	ML028
Nepal	20–29	M	MB	Skin biopsy	New case	2018	ML001
	20–29	F	Unknown	Skin biopsy	New case	2018	ML002
	30–39	M	MB	Skin biopsy	New case	2016	ML004
	30–39	M	PB	Skin biopsy	New case	2016	ML012
Philippines	50–59	F	MB	Skin biopsy	New case	2015	ML005
	40–49	F	MB	Skin biopsy	New case	2015	ML008
	50–59	M	Unknown	Skin biopsy	New case	2019	ML013
	50–59	M	MB	Skin biopsy	New case	2014	ML023

^aMB, multibacillary leprosy; PB, paucibacillary leprosy; unknown, not classified. F, female; M, male.